Clincosm LogoSign in Get a demo

Cervical Cancer

Showing 1 - 25 of 986
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Cervical Cancer, HPV-Related Carcinoma, HPV-Related Malignancy Trial run by the Precigen, Inc (PRGN-2009 plus Pembrolizumab,

Not yet recruiting
  • Cervical Cancer
  • +2 more
  • PRGN-2009 plus Pembrolizumab
  • Pembrolizumab alone
  • Bethesda, Maryland
    National Institute of Health
Nov 27, 2023

Cervical Cancer Trial in China (Disitamab Vedotin, Zimberelimab)

Not yet recruiting
  • Cervical Cancer
  • Bengbu, Anhui, China
  • +11 more
Nov 23, 2023

Cervical Cancer Trial (Adebrelimab)

Not yet recruiting
  • Cervical Cancer
  • (no location specified)
Nov 28, 2023

Cervical Cancer, Cervical Dysplasia, Colposcopy Trial (Coughing at the time of biopsy)

Not yet recruiting
  • Cervical Cancer
  • +4 more
  • Coughing at the time of biopsy
  • (no location specified)
Nov 28, 2023

Cervical Cancer Trial in Heidelberg (MR-guided radiation)

Recruiting
  • Cervical Cancer
  • MR-guided radiation
  • Heidelberg, Germany
    University Hospital of Heidelberg, Radiation Oncology
Nov 15, 2023

Cost-effectiveness Analysis of Cadonilimab in Treatment of

Not yet recruiting
  • Cervical Cancer
  • (no location specified)
Nov 18, 2023

Cervical Cancer, HPV Infection, Acceptability of Health Care Trial in Worldwide (Educational session, Self-sampling, Follow-up

Recruiting
  • Cervical Cancer
  • +2 more
  • Educational session
  • +2 more
  • Ghent, East-Flanders, Belgium
  • +3 more
Nov 14, 2023

HIV, Cervical Cancer Trial in La Jolla, Enugu (Core Implementation strategies, Core+ Enhanced Implementation Strategies)

Not yet recruiting
  • HIV
  • Cervical Cancer
  • Core Implementation strategies
  • Core+ Enhanced Implementation Strategies
  • La Jolla, California
  • +1 more
Nov 13, 2023

Cervical Cancer Trial (Zimberelimab, Platinum, radiotherapy)

Not yet recruiting
  • Cervical Cancer
  • (no location specified)
Nov 9, 2023

Cervical Cancer Trial in Wuhan (Recombinant humanized anti-PD-1 mAb injection, Cisplatin, Bevacizumab Injection)

Not yet recruiting
  • Cervical Cancer
  • Recombinant humanized anti-PD-1 monoclonal antibody injection
  • +4 more
  • Wuhan, Hubei, China
    Tongji Hospital affiliated to Tongji Medical College of Huazhong
Nov 3, 2023

Study on AUNIP as a Novel Tumor Marker for Cervical Cancer

Not yet recruiting
  • Cervical Cancer
  • Detection of serum AUNIP expression
  • (no location specified)
Nov 6, 2023

Breast Cancer, Bowel Cancer, Cervical Cancer Trial (In-person peer-led faith-based intervention to encourage breast, bowel, and

Not yet recruiting
  • Breast Cancer
  • +2 more
  • In-person peer-led faith-based intervention to encourage breast, bowel, and cervical screening uptake among Muslim women
  • Online In-person peer-led faith-based intervention to encourage breast, bowel, and cervical screening uptake among Muslim women
  • (no location specified)
Oct 23, 2023

Early Metastasis in Cervical Cancer Patients After Radiotherapy

Not yet recruiting
  • Cervical Cancer
  • +4 more
  • external pelvic beam radiotherapy (EBRT) followed by individualized high-dose-rate intracavitary brachytherapy (HDR-ICBT)
  • Fuzhou, Fujian, China
    Fujian Cancer Hospital
Oct 21, 2023

HPV-Related Cervical Carcinoma, HPV-Related Malignancy, Cervical Cancer Trial (VB10.16, Atezolizumab Injection [Tecentriq],

Not yet recruiting
  • HPV-Related Cervical Carcinoma
  • +2 more
  • VB10.16
  • +2 more
  • (no location specified)
Oct 24, 2023

Cervical Cancer, Induction Chemo, Immunotherapy Trial in Tianjin (Toripalimab)

Recruiting
  • Cervical Cancer
  • +2 more
  • Tianjin, Tianjin, China
    Tianjin Medical University Cancer Institute & Hospital
Oct 16, 2023

Cervical Cancer Trial (acupuncture)

Not yet recruiting
  • Cervical Cancer
  • acupuncture
  • (no location specified)
Oct 16, 2023

Cervical Cancer Trial in Amsterdam (Anti-PD-1 antibody balstilimab)

Not yet recruiting
  • Cervical Cancer
  • Anti-PD-1 antibody balstilimab
  • Amsterdam, Netherlands
    Amsterdam UMC
Oct 17, 2023

Cervical Cancer, Breast Cancer Trial in Houston (Education, Navigation to clinic)

Completed
  • Cervical Cancer
  • Breast Cancer
  • Education
  • Navigation to clinic
  • Houston, Texas
    The University of Texas Health Science Center at Houston
Oct 9, 2023

NGS-HPV Technology Based on Menstrual Blood

Recruiting
  • Cervical Cancer
    • Wuhan, Hubei, China
      Department of Gynecologic Oncology
    Oct 7, 2023

    Breast Cancer, Cervical Cancer Trial in Houston (Education, Navigation to clinic)

    Recruiting
    • Breast Cancer
    • Cervical Cancer
    • Education
    • Navigation to clinic
    • Houston, Texas
      The University of Texas Health Science Center at Houston
    Oct 9, 2023

    Contribution of PET/MRI in Locally Advanced Cervical Cancer

    Not yet recruiting
    • Cervical Cancer
    • 18-FDG PET-MRI
    • Strasbourg, France
      Institut de cancérologie Strasbourg Europe
    Oct 12, 2023

    Cervical Cancer Trial (printed screening decision aid, a leaftlet, mobile screening decision aid)

    Not yet recruiting
    • Cervical Cancer
    • printed screening decision aid
    • +2 more
    • (no location specified)
    Oct 4, 2023

    AK104 Combined With I-125 Brachytherapy for Recurrent or

    Not yet recruiting
    • Cervical Cancer
    • Iodine-125 particle brachytherapy
    • AK104
    • (no location specified)
    Sep 25, 2023

    Diffuse Astrocytoma, IDH-Mutant, Glioblastoma, IDH-wildtype, Brain Metastases, Adult Trial (NEO212 Oral Capsule, Ipilimumab,

    Not yet recruiting
    • Diffuse Astrocytoma, IDH-Mutant
    • +20 more
    • NEO212 Oral Capsule
    • +8 more
    • (no location specified)
    Sep 18, 2023

    Advanced Solid Tumor, Lung Cancer, Pancreas Cancer Trial in Chengdu (CNSI-Fe(II) 30 mg, CNSI-Fe(II) 60 mg, CNSI-Fe(II) 90 mg)

    Recruiting
    • Advanced Solid Tumor
    • +8 more
    • CNSI-Fe(II) 30 mg
    • +2 more
    • Chengdu, Sichuan, China
      West China Hospital, Sichuan University
    Sep 15, 2023